X-ABT is a diagnostic enterprise specialized in the development of detection solutions for pathogenic microbes.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 24, 2020 | Series B | ¥50M | 1 | — | — | Detail |
Apr 5, 2017 | Post-IPO Equity | ¥20M | 2 | — | — | Detail |
Jun 30, 2016 | Series Unknown | — | 1 | — | — | Detail |